Fig. 1From: Recent advances in pain management based on nanoparticle technologiesMechanism of the action of ZnO nanoparticles with analgesic property. ZnO nanoparticles reduce glutamate release. They are noncompetitive inhibitors of NMDA glutamate receptors; thus, they decrease the capability of glutamate effect in these receptorsBack to article page